Welcome to BioReagent Hub Hotline:19920083827
Development of XYD113 as a potent and highly selective GSPT1 degrader for cancer therapy

ACTA PHARMACOLOGICA SINICA · IF 10.4 · 2026 · DOI: 10.1038/s41401-026-01856-z
Products: β-actin, Mouse mAb 小鼠抗β-actin单克隆抗体;RPMI1640培养基(含L-谷氨酰胺;不含丙酮酸钠,HEPES,双抗);DMEM High Glucose Medium DMEM高糖培养基(含L-谷氨酰胺,丙酮酸钠110 mg/L;不含HEPES,双抗)

Total 904 items / 46 pagesPrev1…1011121314…46Next
✉Email 💬Message 👤Member
↑Top